RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCIE SCOPUS

    Late-onset Neutropenia Following Rituximab Therapy as a Treatment of Diffuse Large B-cell Lymphoma: A Single Institution Study

    한글로보기

    https://www.riss.kr/link?id=A101631468

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Background : Late-onset neutropenia (LON) following rituximab therapy has been reported in recent years. However, its incidence has not been reported in Korea. The aim of this study is to investigate the incidence of LON after rituximab therapy in Korean patients with diffuse large B-cell lymphoma (DLBCL).
    Methods : Ninety-eight cases of DLBCL treated with rituximab between 2004 and 2008 were evaluated. We identified LON as defined by the neutrophil count of <1.5×109/L without apparent cause after the recovery of neutrophil count following rituximab therapy. Bone marrow aspiration and biopsy specimens at the time of neutropenia were available for retrospective review in only 5 of the patients.
    Results : LON was observed in 15 (15.3%) of the 98 patients. In the bone marrow specimens of the 5 patients, promyelocytes were relatively increased and the maturation index of the granulopoiesis was 2:1-3:1, which reflects maturation arrest.
    Conclusions : The incidence of LON following rituximab therapy was 15.3% in Korean patients with DLBCL. Although there are several hypotheses about the causative mechanisms of LON, we suggest that maturation arrest at the promyelocyte stage of granulopoiesis may be one of the mechanisms involved in the development of LON. (Korean J Lab Med 2010;30:575-9)
    번역하기

    Background : Late-onset neutropenia (LON) following rituximab therapy has been reported in recent years. However, its incidence has not been reported in Korea. The aim of this study is to investigate the incidence of LON after rituximab therapy in Kor...

    Background : Late-onset neutropenia (LON) following rituximab therapy has been reported in recent years. However, its incidence has not been reported in Korea. The aim of this study is to investigate the incidence of LON after rituximab therapy in Korean patients with diffuse large B-cell lymphoma (DLBCL).
    Methods : Ninety-eight cases of DLBCL treated with rituximab between 2004 and 2008 were evaluated. We identified LON as defined by the neutrophil count of <1.5×109/L without apparent cause after the recovery of neutrophil count following rituximab therapy. Bone marrow aspiration and biopsy specimens at the time of neutropenia were available for retrospective review in only 5 of the patients.
    Results : LON was observed in 15 (15.3%) of the 98 patients. In the bone marrow specimens of the 5 patients, promyelocytes were relatively increased and the maturation index of the granulopoiesis was 2:1-3:1, which reflects maturation arrest.
    Conclusions : The incidence of LON following rituximab therapy was 15.3% in Korean patients with DLBCL. Although there are several hypotheses about the causative mechanisms of LON, we suggest that maturation arrest at the promyelocyte stage of granulopoiesis may be one of the mechanisms involved in the development of LON. (Korean J Lab Med 2010;30:575-9)

    더보기

    참고문헌 (Reference)

    1 Lemieux B, "Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma" 33 : 921-923, 2004

    2 Saikia TK, "Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin’s lymphoma and corrected with IVIG" 12 : 1493-1494, 2001

    3 Voog E, "Neutropenia in patients treated with rituximab" 348 : 2691-2694, 2003

    4 Terrier B, "Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced Bcell recovery" 92 : e20-e23, 2007

    5 Lai GG, "Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma" 84 : 414-417, 2009

    6 Tesfa D, "Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis" 25 : 374-379, 2008

    7 Hirayama Y, "Late onset neutropenia and immunoglobulin suppression of the patients with malignant lymphoma following autologous stem cell transplantation with rituximab" 48 : 57-60, 2009

    8 Papadaki T, "Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases" 26 : 597-600, 2002

    9 Chaiwatanatorn K, "Delayedonset neutropenia associated with rituximab therapy" 121 : 913-918, 2003

    10 Cattaneo C, "Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments" 47 : 1013-1017, 2006

    1 Lemieux B, "Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma" 33 : 921-923, 2004

    2 Saikia TK, "Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin’s lymphoma and corrected with IVIG" 12 : 1493-1494, 2001

    3 Voog E, "Neutropenia in patients treated with rituximab" 348 : 2691-2694, 2003

    4 Terrier B, "Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced Bcell recovery" 92 : e20-e23, 2007

    5 Lai GG, "Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma" 84 : 414-417, 2009

    6 Tesfa D, "Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis" 25 : 374-379, 2008

    7 Hirayama Y, "Late onset neutropenia and immunoglobulin suppression of the patients with malignant lymphoma following autologous stem cell transplantation with rituximab" 48 : 57-60, 2009

    8 Papadaki T, "Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases" 26 : 597-600, 2002

    9 Chaiwatanatorn K, "Delayedonset neutropenia associated with rituximab therapy" 121 : 913-918, 2003

    10 Cattaneo C, "Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments" 47 : 1013-1017, 2006

    11 Dunleavy K, "B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis" 106 : 795-802, 2005

    12 Nitta E, "A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma:a single-institution study" 18 : 364-369, 2007

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2012-05-21 학술지명변경 한글명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
    외국어명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
    KCI등재
    2011-01-01 등재 학술지 분리 (기타) KCI등재
    2010-06-29 학술지명변경 한글명 : 대한진단검사의학회지 -> The Korean Journal of Laboratory Medicine KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2007-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2005-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2002-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    1999-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 1.51 0.18 1.15
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.91 0.81 0.458 0.08
    더보기
    해외이동버튼